Skip to main content
. Author manuscript; available in PMC: 2009 Apr 3.
Published in final edited form as: Hear Res. 2007 Jun 27;232(1-2):1–19. doi: 10.1016/j.heares.2007.06.011

Table 1.

Concentration of specific cytoskeletal inhibitors and their actions.

Compound Inhibitor of: Concentration Reference
Latrunculin A Actin polymerization 5 µM (Rosenblatt et al., 2001)
Cytochalasin D Actin polymerization 1 µM (Rosenblatt et al., 2001)
Taxol (Paclitaxel) Microtubule depolymerization 0.1 µM (Kim et al., 2002; Platts et al., 1999)
Colchicine Microtubule polymerization 10 µM (Platts et al., 1999)
ML-9 Myosin light chain kinase 200 µM (Rosenblatt et al., 2001)
Y-27632 Rho-kinase (blocks contraction) 100 µM (Rosenblatt et al., 2001)